Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...

Celebrities have access to doctors that most others don’t,” says Jameela Jamil, who flagged the risks of GLP-1s like those ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Serena Williams has just publicly admitted to using GLP-1 medication for weight loss. The 23-time Grand Slam champion says ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

With 23 Grand Slam singles titles and four Olympic gold medals, Serena Williams is undeniably a superathlete. But the 43-year ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...